News and Events
|
News Release
NIH-funded study focused on original virus strain, unvaccinated participants during pandemic Infection from COVID-19 appeared to significantly increase the risk of heart attack, stroke, and death for up to three years among unvaccinated people early in the pandemic when the original SARS-CoV-2 virus strain emerged, according to a National...
|
Research Feature
A new solution to an old problem makes breath analysis in real time possible The breath we exhale can tell us a lot about our respiratory and metabolic health – like whether we have asthma or if we might be developing kidney disease or need to better manage a case of COPD. But the breath is famously hard to study, especially in real time....
|
Research Feature
Sickle cell disease (SCD) is a group of painful and life-threatening genetic disorders that affect hemoglobin, the major protein that carries oxygen in red blood cells. It occurs in nearly 100,000 people in the United States and millions worldwide. The most common type is hemoglobin SS (HbSS), which affects about 65% of those with sickle cell...
|
Research Feature
The aorta, one of the “great arteries,” carries blood away from the heart to support circulation throughout the body. However, sometimes a tear in the lining of the aorta can occur, and while this is uncommon, it often requires immediate treatment. That’s why it’s important for people to be aware of common risk factors and symptoms. Sujata M...
Upcoming Events
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) is hosting a two-day virtual workshop titles "Disparities across the spectrum of pulmonary vascular disease (PVD)" - scheduled for October 22 - 23, 2024, from 10:00 AM to 5:40 PM (EST).
October
22
-
23
,
2024
Virtual (webinar)
October 22, 2024, 10:00 a.m. - 5:30 p.m. EST
October 23, 2024, 10:00 a.m. - 5:40 p.m. EST
October 22, 2024, 10:00 a.m. - 5:30 p.m. EST
October 23, 2024, 10:00 a.m. - 5:40 p.m. EST
The NHLBI has been focusing on heart, lung, blood, and sleep (HLBS) disorders and exploring technologically-based solutions to improve health. After a virtual workshop in May 2022, they identified opportunities for pursuing synthetic biological tools in the context of these disorders and signed onto the Notice of Special Interest for Synthetic Biology for Biomedical Applications. The NHLBI aims to establish partnerships between scientists and bioengineers to develop synthetic biological tools targeting HLBS disorders, with the goal of addressing obstacles and encouraging applications leading to a peer-reviewed whitepaper detailing progress and outcomes.
November
4
-
5
,
2024
Virtual
12:00 p.m. - 5:00 p.m. ET
12:00 p.m. - 5:00 p.m. ET
This workshop will assess the progress made towards implementation of the COPD National Action Plan since its release. We will also reengage the COPD community around using the COPD National Action Plan Community Action Tool to track and monitor progress.
Virtual
9:30 a.m. - 3:30 p.m. ET
9:30 a.m. - 3:30 p.m. ET
Featured Past Events
Join the Learn More Breathe Better® program and guest speakers from the Breathe Better Network as we discuss how people in all stages of life can protect their lungs from COPD and how people living with the disease can manage it. We will also highlight educational resources available to use during National COPD Awareness Month in November and beyond.
Virtual
2:00 p.m. - 3:00 p.m. ET
2:00 p.m. - 3:00 p.m. ET
The meeting of the National Commission on Lymphatic Diseases scheduled for September 30, 2024 bring together a multidisciplinary panel of stakeholders and experts who are at the forefront of their respective fields. The planned discussions will play a crucial role in shaping the conversation to improve fundamental knowledge, implementation of practice guidelines, and addressing gaps and disparities in the diagnosis, therapeutics, and access to care for lymphatic disease (LD).
Virtual
9:10 a.m. - 2:20 p.m. ET.
9:10 a.m. - 2:20 p.m. ET.
Obesity contributes to diseases of the heart-including atherosclerotic cardiovascular disease, arrhythmias, and heart failure with preserved ejection fraction-which often are refractory to treatment. This symposium explores the epidemiology and pathophysiology of obesity-related heart diseases, as well as the role of emerging therapeutics and issues related to prevention, access to treatment, and health equity.
Virtual (webinar)
9:00 am - 3:00 pm (ET)
9:00 am - 3:00 pm (ET)